Your Mounjaro price guide · October 2026
Is Mounjaro Safe Long Term? What We Know (October 2026)
Mounjaro (tirzepatide) is a licensed UK medicine used under prescriber supervision, and the main obesity trial followed people for 72 weeks.2 Longer-term evidence is still building, so ongoing reviews matter.
One pen. Four weekly doses.
New customers£40 off your first order with code FIRST40. Standard price £169.99.

From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
The honest long-term picture
Long-term safety is about what the trials show, what regulators keep watching, and what we do not yet know.
- Price includes prescriber assessment and standard delivery — no consultation fees
- Orders approved by 3pm for next-day tracked delivery
- GPhC-registered pharmacy 9012878
- Needles and sharps disposal included
Compare UK Mounjaro Prices
Prices checked 10 October 2026
| Provider | 2.5mg | 5mg | 7.5mg | 10mg | 12.5mg | 15mg | Notes |
|---|---|---|---|---|---|---|---|
| £129.99First orderReorders £144.99 | £178.99First orderReorders £193.99 | £239.99First orderReorders £254.99 | £250.99First orderReorders £265.99 | £279.99First orderReorders £294.99 | £289.99First orderReorders £304.99 | Consultation and next-day tracked delivery included | |
| Boots Online Doctor | £179.00 | £199.00 | £259.00 | £299.00 | £319.00 | £339.00 | Free click & collect; cold-chain home delivery chargeable |
| Asda Online Doctor | £148.97 | £188.97 | £248.97 | £278.97 | £287.47 | £298.97 | Refrigerated delivery from £4.50; free click & collect |
| MedExpress | £179.99 | £189.99 | £249.99 | £279.99 | £299.99 | £309.99 | Delivery £2.90 to £3.95; new-customer discount at checkout |
| Simple Online Pharmacy | £169.00 | £199.99 | £259.99 | £279.99 | £299.99 | £319.99 | Delivery £4.99 per order |
| Oxford Online Pharmacy | £143.96 | £188.96 | £248.96 | £278.96 | £288.96 | £309.95 | Free consultation; cold delivery £5.49 |
| Chemist4U | £148.00 | £188.00 | £248.00 | £278.00 | £288.00 | £298.00 | Consultation included; free temperature-controlled delivery |
| Chemist Click | £163.99 | £173.99 | £232.99 | £259.99 | £279.99 | £299.49 | Cold-chain delivery charged; £20 off with code |
| Click Pharmacy | £169.99 | £189.99 | £239.99 | £269.99 | £289.99 | £299.99 | Free assessment; delivery £3.50 to £7.95 |
| Medino | £147.99 | £169.99 | £249.99 | £269.99 | £299.99 | £319.99 | Consultation and delivery included |
Prices collected weekly from each provider's published price list.
A quick overview
What to know
before you start.
-
Mounjaro is licensed in the UK for weight management and is used long term under regular prescriber review, not as a short course.
-
The main obesity trial ran for 72 weeks, so evidence beyond that period is still accumulating.
-
Serious side effects are uncommon but need medical help straight away: severe persistent stomach pain, gallbladder symptoms or allergic reactions.
-
Kidneys and liver are not directly harmed, but vomiting or diarrhoea can cause dehydration, which is the practical risk.
-
Tirzepatide takes four to five weeks to clear after a final dose, so plan any stop or switch with your prescriber.
In this guide
01 · The core answer
Is it safe to take Mounjaro long term?
For suitable adults, yes: it is a licensed prescription medicine intended for ongoing use alongside a reduced-calorie diet and increased physical activity, with regular review by a prescriber. That is not the same as risk-free, and nobody can honestly claim decades of data on a medicine this new.
Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly.1 In the UK it is licensed for weight management in adults and for type 2 diabetes.1 Our full long-term safety guide goes deeper on the same question.
| Area | What the evidence says | What you should do |
|---|---|---|
| Serious side effects | Uncommon, but need urgent attention (pancreatitis, gallbladder problems, severe allergy).13 | Know the warning signs and get medical help straight away. |
| Thyroid | Thyroid tumours seen in rodents; no increase shown in human trials.1 | Tell your prescriber about any personal or family thyroid cancer history. |
| Kidneys and liver | Not known to damage them directly; dehydration is the indirect risk.1 | Keep fluids up; get in touch if you cannot keep fluids down. |
| Mood | The EMA safety committee concluded in 2024 that the evidence does not support a causal link with low mood or suicidal thoughts; the MHRA keeps it under review.17 | Tell your prescriber about any change in your mood, and seek help promptly if your mood drops. |
| Heart and metabolic markers | Trial averages improved for blood pressure, cholesterol and blood sugar.2 | Keep up your reviews so benefits are tracked in you, not just in averages. |
| Very long-term data | Evidence beyond the trial periods is still accumulating. | Stay under supervision and report new symptoms via the Yellow Card scheme.19 |
If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.
02 · Your next step
Is long-term use right for you?
That depends on your health history, your goals and how you tolerate treatment. Long-term safety is not decided once: it is checked at each review. Those who suit treatment best have shared their full medical history and medicine list and accept that regular follow-up is part of the deal.
If you are weighing treatment up, start with our weight loss clinic overview. Consultation is free and reviewed by a GPhC-registered prescriber, and ongoing monthly reviews are part of our aftercare.
03 · What the trials cover
What the long-term evidence actually covers
The main obesity trial, SURMOUNT-1, ran for 72 weeks, which is well over a year but is not a decade.2
Trial results are averages and individual results vary; treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.2 The trial tells us about effectiveness and tolerability over that period.
Regulators fill part of that gap. Medicines are monitored after licensing through reports from prescribers and patients, which is why the Yellow Card scheme matters. If something new happens to you, reporting it helps everyone.19
04 · Serious side effects
Serious side effects to know about
Serious side effects are uncommon but need urgent attention. Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting, which could be pancreatitis.13
Also get medical help straight away for pain in the upper right abdomen, fever or yellowing of the skin or eyes, which could signal gallbladder problems. Get medical help straight away for signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.13
If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar, such as shakiness, sweating or confusion. Your prescriber may need to adjust those medicines.13
Can you prevent pancreatitis? There is no proven way to prevent pancreatitis or gallbladder problems while taking Mounjaro. Before you start, tell your prescriber if you have ever had pancreatitis, gallstones or gallbladder disease, or severe problems with your digestion. For a wider view, see Mounjaro risks over the long term.
05 · Thyroid, kidneys, liver
Thyroid, kidney and liver safety
In rodent studies tirzepatide caused thyroid C-cell tumours; it is not known whether this applies to humans, and no increase has been shown in human trials.1 As a precaution, tell your prescriber if you or a close relative have had medullary thyroid cancer or the inherited condition MEN 2, because they will weigh this in your assessment.1 Routine thyroid monitoring is not required for most people.1
Mounjaro is not known to damage kidneys or liver directly, and no dose adjustment is needed for mild to moderate kidney or liver impairment.1 The practical risk is indirect: severe vomiting or diarrhoea can cause dehydration, which can strain the kidneys.1 Keep fluids up and get medical help straight away if you cannot keep fluids down. People with severe impairment need individual prescriber assessment.
06 · Mood and mental health
Mood and mental health over time
Regulators have looked specifically at whether GLP-1 medicines are linked to low mood or suicidal thoughts: the EMA's safety committee reviewed the evidence and concluded in 2024 that it does not support a causal link, and the MHRA keeps this under continuous review.17
That said, any big change in weight, appetite and routine can affect how you feel. Tell your prescriber about any history of depression, and seek help promptly if your mood drops or you have distressing thoughts during treatment.17
07 · Who should not take it
Who should avoid Mounjaro, and what to avoid on it
You should not take Mounjaro if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive.13 Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems.13
On the question of what to avoid while taking it: Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed.7 The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.1 Insulin and sulfonylurea doses may need adjusting. Always share your full medical history and medicine list during consultation. Our guide to whether it is safe to take Mounjaro covers the starting decision.
08 · Stopping Mounjaro
What happens when you stop taking Mounjaro
Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.1
Once it has cleared, you no longer have the medicine working on appetite and stomach emptying. Those effects are how it supports a reduced-calorie diet, so stopping means you rely on diet, activity and habits alone.1 Plan a stop with your prescriber rather than abruptly, and ask what support will replace the medicine.
Will you regain weight if you stop? In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average.14 Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load.
This is also where the health benefits come in. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.2 These are trial-average secondary outcomes, not promises, but they are the reason weight management is framed as health management. Whether these gains persist after stopping is something to discuss with your prescriber.
09 · Staying on for life
Can you stay on Mounjaro for life?
The question is whether it is still helping, still tolerated and still right for your health.
Reasons to keep going include sustained benefit and good tolerance. Reasons to reconsider include side effects that do not settle, a change in your medical history such as pregnancy plans, or a different treatment becoming more suitable. Our guides on being on Mounjaro long term and what long-term use looks like explain how reviews work in practice.
We do not use subscriptions and repeat orders re-check suitability, with no auto-shipping.
10 · Mounjaro vs other options
Mounjaro, Ozempic and supplements: which is safer?
No licensed medicine is safer for everyone. Mounjaro and semaglutide products such as Wegovy are both licensed treatments with their own safety information, and the right one depends on your history and how you respond. In SURMOUNT-5, the first large head-to-head trial, tirzepatide was compared directly with semaglutide; a prescriber can help you interpret it. If you want to look at the alternative, see the Wegovy pen.
Ozempic is semaglutide licensed for type 2 diabetes only; it is not a UK weight-loss medicine, and a regulated UK pharmacy will not supply it for weight loss. The "poor man's Ozempic" or "natural Ozempic" labels usually describe a low-cost supplement such as berberine, with no clinical oversight and dosing that is not standardised. It is not a licensed alternative to prescription treatment, and dramatic weight-loss claims around such products should be treated sceptically.
Be wary of the "poor man's Ozempic" or "natural Ozempic" labels. Licensed tablet options exist, and a prescriber can explain which fits you. Anyone offering to supply a prescription medicine without a consultation or prescription is a red flag, so only buy from a GPhC-registered pharmacy; ours is GPhC 9012878.
11 · NHS access
NHS access and long-term monitoring
Mounjaro is available on the NHS, but access is being phased in over several years.4 NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).6
Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting. Whichever route you take, long-term safety depends on the same things: honest history, regular reviews and prompt reporting of symptoms. For a more cautious framing of the same topic, read whether Mounjaro is dangerous long term and staying on it safely.
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Mounjaro price UK — frequently asked questions
Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.
Ask our pharmacy teamWhat are the long-term effects of Mounjaro?
Can you stay on Mounjaro for life?
Which is safer, Mounjaro or Ozempic?
What should I avoid while taking Mounjaro?
Can I prevent pancreatitis on Mounjaro?
What is known as the poor man's Ozempic?
Has anyone kept the weight off after stopping Mounjaro?
Is there a natural alternative to Ozempic for weight loss?

Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 9 references
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med 2022;387:205–216
- NICE TA1026 — Tirzepatide for managing overweight and obesity, including the practical prescribing guide
- NHS England — Weight management injections: rollout guidance
- MHRA — guidance on contraception with GLP-1/GIP medicines; counterfeit medicine alerts and Yellow Card scheme
- Mounjaro KwikPen — Patient Information Leaflet (emc)
- Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). N Engl J Med 2025
- Wegovy — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC)
- MHRA Yellow Card scheme — report a side effect
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel


